Clinical Investigation of an Eye-Tracking Device as a Predictor of Delirium in the Recovery Room After Surgery With General Anesthesia
2 other identifiers
observational
325
1 country
1
Brief Summary
Neurotrack™ is an FDA-approved device for measuring and tracking cognitive decline, as may occur with age-related cognitive decline and Alzheimer's disease. The device uses a webcam (World Wide Web enabled camera) to assess eye-tracking as the subject views black-and-white images on the computer screen. The test takes less than 5 minutes to complete. This study will examine the feasibility and utility of pre-operative assessment of cognition using Neurotrack™ technology. The predictive value of Neurotrack™ will be compared to our previous work using pupillometry. The primary outcome is a measure of delirium in the recovery room and secondary outcomes include total length of stay, intensive care unit (ICU) length of stay, and readmissions within 30 days of surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2021
CompletedFirst Submitted
Initial submission to the registry
May 23, 2022
CompletedFirst Posted
Study publicly available on registry
October 13, 2022
CompletedMay 24, 2023
May 1, 2023
2 years
May 23, 2022
May 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of delirium
Prevalence of delirium in in the post anesthesia care unit (PACU) will be calculated.
Up to 2 years
Interventions
Patients will be put into a quiet room with a computer and a webcam for a five minute assessment with the NeuroTrack™ testing. Study personnel will stay in the room, and be available for answering questions about using the online testing tool. After Neurotrack, pupillary responses will be recorded with the pupillometer with the PLR -3000TM. In brief, an eye cup attached to a pupillometer will be placed over one eye to allow measurement of the pupillary response to light. Once the eye cup is properly positioned, the reading takes approximately 5 seconds, after which time the eye cup will be removed. The reading will then be taken in the contralateral eye.
Eligibility Criteria
Sign-up for the protocol will be based upon a review of the preoperative and pre-op clinic schedules, a recommendation from operating room physicians or referral from preoperative anesthesia consultant at the conclusion of their preoperative clinic visit. A clinical research coordinator or other research personnel is available to answer questions and obtain informed consent from the patient. It will be made clear to the patient that study participation is optional and that they can "opt out" at any time even if they have signed a consent form. We intend on enrolling male and female patients that meet eligibility criteria.
You may qualify if:
- Age 18 years or greater
- Any American Society of Anesthesiologists (ASA) classification
- Scheduled elective surgery with general anesthesia. Extubation, and emergence anticipated in the operating room and recovery in the post-operative care unit (PACU).
You may not qualify if:
- Cardiac surgery (on or off cardiopulmonary bypass).
- Intracranial neurosurgery
- Surgery involving the eye, eyebrow, forehead, or frontal scalp near the eyes
- Emergency surgery
- Monitored Anesthesia Care (i.e., regional anesthesia alone without anticipated plans for general anesthesia)
- Poor health literacy ("How confident are you filling out medical forms by yourself?")
- Endotracheal intubation maintained upon leaving operating room
- Direct admission to ICU due to foreseen or unforeseen circumstances
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emory University Hospital
Atlanta, Georgia, 30322, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul S. Garcia, MD, PhD
Columbia University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2022
First Posted
October 13, 2022
Study Start
October 1, 2019
Primary Completion
September 20, 2021
Study Completion
September 20, 2021
Last Updated
May 24, 2023
Record last verified: 2023-05